Welcome to the resource library, where you can find strategy, research and examples of promising practice in medicine, commissioning and drug services for hepatitis C

Showing 311 to 320 of 356 resources

  • NHS Liver Care E-seminar: Making Every Contact Count
    This document provides a summary of the key points made by Professor Martin Lombard, National Clinical Director for Liver Disease, during an NHS presentation he gave. He provides an overview of the high prevalence of liver disease in England and discusses the reasons for this high prevalence and what measures could be taken to lower the number of cases of liver disease. The document also provides a link to listen to the e-seminar.
    England 13 Jun 2012 Other MS Word
  • Hepatitis C Prevalence and Incidence among Scottish Prisoners and Staff Views of its Management: Final Report
    This report aims to generate reliable data on prevalence and incidence of hepatitis C to inform the Scottish Prison Service and the NHS to develop effective needs-led interventions for hepatitis C (HCV) infected prisoners, and to enable an informed assessment of the effectiveness of measures to prevent the spread of blood borne viruses, especially hepatitis C, within the prison setting, as outlined in the Hepatitis C (Phase (II)) Action Plan for Scotland (2008).
    England, Scotland May 2012 Reports & Research PDF
  • Health and Social Care Act 2012
    The Health and Social Care Act 2012 aims to safeguard the future of the NHS by modernising it to better tackle the problems of today and avoid crisis tomorrow. It sets out a plan to put clinicians at the centre of commissioning, freeing up providers to innovate, empowering patients and giving a new focus to public health.
    England 27 Mar 2012 Other PDF
  • Guidance on testing for hepatitis B and C (with reference to HIV) Developed by Yorkshire and the Humber Hepatitis B and C Steering Group
    Individuals with chronic hepatitis (B and C) can be treated, which reduces the likelihood of chronic illness and premature death. Recognition of infection and treatment may also reduce the spread of infection. In 2010 across Yorkshire and the Humber there were 427 cases of hepatitis B (of which 39 were acute) and 980 newly identified hepatitis C infections reported through NHS/HPA laboratory testing, however HPA estimates calculate that there are over 20,000 people actually infected with hepatitis C in the region.
    Yorkshire and the Humber Mar 2012 Tools & Templates, Strategy & Planning PDF
  • Deaths from liver disease: Implications for end of life care in England - March 2012
    This report presents key facts about deaths from liver disease in England. It highlights differences in place and cause of death by age, sex and deprivation. It is aimed at commissioners and providers of end of life care, clinicians caring for patients with liver disease, and others concerned with providing quality end of life care for this patient group, including patients themselves and their carers. The report gives the first summary of high level statistics on deaths from liver disease on which future discussions can be built.
    England Mar 2012 Reports & Research PDF
  • Yorkshire and the Humber Quality Standards Framework for Hepatitis B and C: 2012
    In order to address the prevention and burden of hepatitis C (and B) effectively it is important that the four key elements of the pathway are in place as defined by the Department of Health. Whilst there have been many developments since 2004, this Quality Standards Framework still focuses on the four key elements of the hepatitis B and C pathway but provides more detail on how, in Yorkshire and the Humber, stakeholders can work effectively to deliver a quality pathway to patients regarding hepatitis B and C.
    Yorkshire and the Humber 2012 Other, Reports & Research PDF
  • The Hepatitis C Trust Outreach & Testing Van
    This document summarises The Hepatitis C Trust’s Outreach and Testing Van service, which aims to increase diagnoses by reaching groups who may be at risk of hep C but who currently cannot, or do not, access testing through existing means. Given that most people in the UK today are undiagnosed, the testing van aims to overcome some of the key barriers to diagnosis.
    England 2011 Case study, Reports & Research PDF
  • Wirral Drug and Alcohol Addiction Team (DAAT) Hep C Strategy
    The National Treatment Agency’s (NTA) aspirational target is for each DAAT partnership to ensure that 100% of their previous/current injecting drug user (IDU) population to have been tested for Hepatitis C. Many DAATs across the country have struggled to achieve this target and Wirral DAAT’s performance at the end of 2007/08 is at 20%.
    North West 2011 Case study, Strategy & Planning PDF
  • The Sexual Health and Blood Borne Virus Framework 2011-15
    Sexual health and blood borne viruses continue to be of high priority for the Scottish Government. The Sexual
    Scotland Aug 2011 Reports & Research PDF
  • Pharmacy-based testing for hepatitis B and hepatitis C
    This report lays out The Hepatitis C Trust’s plan for a programme of pharmacy-based testing for hepatitis b and hepatitis c. It emphasises that community pharmacies are ideally placed to deliver basic public health information as well as, with the right training and support, screening for conditions such as viral hepatitis. The Hepatitis C Trust’s Pharmacy Testing Programme is designed to increase awareness and testing for hepatitis B and C through targeted, on-demand testing for people less likely to access mainstream services.
    UK 26 Jun 2011 Reports & Research PDF